✦ LIBER ✦

High (120 mg/m2) versus lower (60 mg/m2 dose of cisplatin (CDDP) in combination with etoposide in the treatment of non small cell carcinoma (NSCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A combination of 60 mg/m2 cisplatin (CDD

✍ Giner, V.; Sculier, J.P.; Klastersky, J.; Bureau, G.; Thiriaux, J.; Efremidis, A 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A phase II trial of low-dose docetaxel (

✍ Kusaba, H; Nakamura, Y; Kunitoh, H; Sekine, I; Kubota, K; Tamura, T; Shinkai, T; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 120 KB

A randomised trial comparing chemotherap

✍ Sculier, J.P; Lafitte, J.J; Thiriaux, J; Alexopoulos, C.G; Baumöhl, J; Koumakis, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

147 Phase II studies of a 60 mg/m2 dose

✍ Hiraki, S.; Watanabe, K.; Furuse, K.; Kudo, S.; Ohnoshi, T.; Niitani, H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Drug therapy of the non-small cell bronc

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 98 KB

63 Navelbine (NVB), and fractionated dos

✍ Rodrigues, J.; Pawlicki, M.; Firat, D.; Altino, J.; Krawczyk, K.; Barista, ; Le 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 159 KB